Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IDEAYA Biosciences (IDYA) Invested Capital: 2019-2025

Historic Invested Capital for IDEAYA Biosciences (IDYA) over the last 7 years, with Sep 2025 value amounting to $1.1 billion.

  • IDEAYA Biosciences' Invested Capital fell 7.49% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 7.49%. This contributed to the annual value of $1.1 billion for FY2024, which is 70.53% up from last year.
  • As of Q3 2025, IDEAYA Biosciences' Invested Capital stood at $1.1 billion, which was up 13.79% from $959.7 million recorded in Q2 2025.
  • Over the past 5 years, IDEAYA Biosciences' Invested Capital peaked at $1.2 billion during Q3 2024, and registered a low of $233.1 million during Q1 2021.
  • Its 3-year average for Invested Capital is $831.5 million, with a median of $935.3 million in 2024.
  • In the last 5 years, IDEAYA Biosciences' Invested Capital surged by 180.19% in 2024 and then decreased by 7.49% in 2025.
  • Quarterly analysis of 5 years shows IDEAYA Biosciences' Invested Capital stood at $301.5 million in 2021, then increased by 15.90% to $349.5 million in 2022, then spiked by 77.73% to $621.1 million in 2023, then soared by 70.53% to $1.1 billion in 2024, then declined by 7.49% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q3 2025, $959.7 million for Q2 2025, and $1.0 billion during Q1 2025.